Filter
1042
Text search:
Health
Care
Without
Harm
Asia
Featured
Recommendations
115
New Publications
232
Language
Document type
No document type
578
Studies & Reports
194
Guidelines
142
Manuals
62
Strategic & Response Plan
25
Training Material
21
Fact sheets
8
Situation Updates
6
Infographics
4
Resource Platforms
1
Online Courses
1
Countries / Regions
Global
67
Western and Central Europe
34
India
29
Myanmar / Burma
23
South–East Asia Region
20
Asia
18
Ukraine
17
Nepal
13
Bangladesh
13
Indonesia
12
Syria
11
Eastern Europe and Central Asia
11
Latin America and the Carribbean
10
Eastern Europe
10
Philippines
9
Nigeria
8
Ethiopia
7
Afghanistan
7
Middle East and North Africa
7
Liberia
6
Uganda
6
Pakistan
6
Zambia
6
Tanzania
6
Cambodia
6
West and Central Africa
6
Africa
6
Russia
6
Thailand
5
East and Southern Africa
5
Western Pacific Region
5
Tajikistan
5
Vietnam
5
South Africa
4
Georgia
4
Sierra Leone
3
Congo, Democratic Republic of
3
Zimbabwe
3
Kenya
3
Namibia
3
Yemen
3
Iran
3
Guinea
2
USA
2
Ghana
2
Somalia
2
South Sudan
2
China
2
Malaysia
2
Malawi
2
North Macedonia
2
Croatia
2
Albania
2
Laos
2
Moldova
2
Kyrgyzstan
2
Japan
2
Senegal
1
Haiti
1
Jordan
1
Turkey
1
Rwanda
1
Singapore
1
Papua New Guinea
1
Central African Republic
1
Eswatini/ Swaziland
1
Brazil
1
Serbia
1
Colombia
1
Ecuador
1
Botswana
1
Lesotho
1
Mexico
1
Venezuela
1
Armenia
1
Qatar
1
Lithuania
1
Uzbekistan
1
Kazakhstan
1
North America
1
Turkmenistan
1
Portugal
1
Spain
1
Azerbaijan
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
163
Clinical Guidelines
116
Women & Child Health
106
Public Health
76
Key Resources
41
Capacity Building
23
Pharmacy & Technologies
9
General Guidelines
2
Toolboxes
HIV
211
Mental Health
146
COVID-19
77
Planetary Health
50
TB
42
Refugee
33
Caregiver
33
Conflict
32
Global Health Education
29
Disability
28
Rapid Response
23
AMR
22
Natural Hazards
13
Pharmacy
12
Health Financing Toolbox
12
Specific Hazards
10
NCDs
10
Ebola
9
NTDs
9
Zika
5
Polio
4
Social Ethics
4
Cholera
3
Health Financing
1
mhGAP is based on evidence-based technical guidelines (4) and provides a set of tools and
training packages to extend service provision. The mhGAP Intervention Guide (mhGAP-IG)
for MNS disorders in non-specialized health settings (8) is a clinical
...
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structu
...
Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care
...
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three
...
The WHO Guidelines on risk reduction of cognitive decline and dementia provide evidence-based recommendations on lifestyle behaviours and interventions to delay or prevent cognitive decline and dementia. These WHO Guidelines are an important tool for healt
...
In the framework of the United Nations Sustainable Development Goals Issue-based Coalition on Health and Well-being for All at All Ages in Europe and Central Asia
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i
...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant
...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative
...
Rabies is fatal, vaccine-preventable disease responsible for an estimated 59,000 human deaths each year. Most cases are transmitted by dogs, and most deaths occur in underserved populations in Africa and Asia. Approximately 40% of deaths occur in ch
...
Evidence for technical update of pocket book recommendations. Newborn conditions, dysentery, pneumonia, oxygen use and delivery, common causes of fever, severe acute malnutrition and supportive care
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei
...
This new guideline on non-clinical interventions to reduce unnecessary caesarean sections incorporates the views, fears and beliefs of both women and health professionals about caesarean sections. It also considers the complex dynamics and limitatio
...
This technical guidance outlines current evidence, knowledge and best practice relating to incidences of violence and injuries among refugees and migrants in the WHO European Region. It highlights key principles, summarizes priority actions and challenges, maps existing international commitments and
...
More than 700 000 people lose their life to suicide every year. The world is not on track to reach the 2030 suicide reduction targets. WHO advocates for countries to take action to prevent suicide, ideally through a comprehensive national suicide prevention strategy. Governments and communities can
...
The primary audience for this guidance is persons
working directly in vector-borne disease prevention
and control, including programme managers,
researchers and field workers. A brief technical
background is provided for the benefit of persons
without
...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and pe
...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u
...
This document is an output of a WHO cross-programme initiative aiming to improve the prevention, diagnosis and management of anaemia and thereby accelerate reduction in its prevalence. It comes at an important time, midway through the era of the Sustainable Development Goals, when progress in reduci
...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im
...
